Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation

Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex

Kevin Rostasy, Laura Monti, Constantin Yiannoutsos, Michelle Kneissl, Jeanne Bell, Thomas L. Kemper, John C. Hedreen, Bradford A. Navia

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

The regional expression of immune-mediated and neurotoxic events in the human immunodeficiency virus (HIV)infected brain in relationship to the acquired immunodeficiency syndrome (AIDS) dementia complex (ADC) and brain pathology remains uncertain. The extent of gp41, inducible nitric oxide synthase (iNOS), and HLA-DR expression was examined in the frontal lobe and basal ganglia of 25 patients at varying stages of ADC. The expression of gp41 and iNOS was present predominantly in perivascular cells and most often in the basal ganglia. Staining for gp41 correlated significantly with iNOS in the basal ganglia, whereas the severity of staining for gp41 and iNOS in the basal ganglia and white matter was significantly greater in subjects with moderate to severe dementia compared with those with milder impairment. The degree of macrophage staining in the white matter and basal ganglia also correlated significantly with ADC severity and was more abundant than gp41 or iNOS staining, particularly in the white matter. Logistic regression analysis revealed that staining for iNOS and gp41 increased linearly with ADC severity and was significantly more abundant in the basal ganglia compared with the white matter. Double-immunolabeling studies colocalized iNOS predominantly to macrophage/microglia and to gp41-positive cells. The expression of iNOS and gp41 in the basal ganglia combined with immune activation contributes to the development and progression of the clinical syndrome.

Original languageEnglish (US)
Pages (from-to)207-216
Number of pages10
JournalAnnals of Neurology
Volume46
Issue number2
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Nitric Oxide Synthase Type II
Virus Diseases
Basal Ganglia
Dementia
Acquired Immunodeficiency Syndrome
HIV
AIDS Dementia Complex
Staining and Labeling
Macrophages
Brain
Microglia
Frontal Lobe
HLA-DR Antigens
Logistic Models
Regression Analysis
Pathology
White Matter

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation : Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. / Rostasy, Kevin; Monti, Laura; Yiannoutsos, Constantin; Kneissl, Michelle; Bell, Jeanne; Kemper, Thomas L.; Hedreen, John C.; Navia, Bradford A.

In: Annals of Neurology, Vol. 46, No. 2, 1999, p. 207-216.

Research output: Contribution to journalArticle

Rostasy, Kevin ; Monti, Laura ; Yiannoutsos, Constantin ; Kneissl, Michelle ; Bell, Jeanne ; Kemper, Thomas L. ; Hedreen, John C. ; Navia, Bradford A. / Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation : Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. In: Annals of Neurology. 1999 ; Vol. 46, No. 2. pp. 207-216.
@article{c81b526c828d474299cf44c5d800aafd,
title = "Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex",
abstract = "The regional expression of immune-mediated and neurotoxic events in the human immunodeficiency virus (HIV)infected brain in relationship to the acquired immunodeficiency syndrome (AIDS) dementia complex (ADC) and brain pathology remains uncertain. The extent of gp41, inducible nitric oxide synthase (iNOS), and HLA-DR expression was examined in the frontal lobe and basal ganglia of 25 patients at varying stages of ADC. The expression of gp41 and iNOS was present predominantly in perivascular cells and most often in the basal ganglia. Staining for gp41 correlated significantly with iNOS in the basal ganglia, whereas the severity of staining for gp41 and iNOS in the basal ganglia and white matter was significantly greater in subjects with moderate to severe dementia compared with those with milder impairment. The degree of macrophage staining in the white matter and basal ganglia also correlated significantly with ADC severity and was more abundant than gp41 or iNOS staining, particularly in the white matter. Logistic regression analysis revealed that staining for iNOS and gp41 increased linearly with ADC severity and was significantly more abundant in the basal ganglia compared with the white matter. Double-immunolabeling studies colocalized iNOS predominantly to macrophage/microglia and to gp41-positive cells. The expression of iNOS and gp41 in the basal ganglia combined with immune activation contributes to the development and progression of the clinical syndrome.",
author = "Kevin Rostasy and Laura Monti and Constantin Yiannoutsos and Michelle Kneissl and Jeanne Bell and Kemper, {Thomas L.} and Hedreen, {John C.} and Navia, {Bradford A.}",
year = "1999",
doi = "10.1002/1531-8249(199908)46:2<207::AID-ANA10>3.0.CO;2-4",
language = "English (US)",
volume = "46",
pages = "207--216",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation

T2 - Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex

AU - Rostasy, Kevin

AU - Monti, Laura

AU - Yiannoutsos, Constantin

AU - Kneissl, Michelle

AU - Bell, Jeanne

AU - Kemper, Thomas L.

AU - Hedreen, John C.

AU - Navia, Bradford A.

PY - 1999

Y1 - 1999

N2 - The regional expression of immune-mediated and neurotoxic events in the human immunodeficiency virus (HIV)infected brain in relationship to the acquired immunodeficiency syndrome (AIDS) dementia complex (ADC) and brain pathology remains uncertain. The extent of gp41, inducible nitric oxide synthase (iNOS), and HLA-DR expression was examined in the frontal lobe and basal ganglia of 25 patients at varying stages of ADC. The expression of gp41 and iNOS was present predominantly in perivascular cells and most often in the basal ganglia. Staining for gp41 correlated significantly with iNOS in the basal ganglia, whereas the severity of staining for gp41 and iNOS in the basal ganglia and white matter was significantly greater in subjects with moderate to severe dementia compared with those with milder impairment. The degree of macrophage staining in the white matter and basal ganglia also correlated significantly with ADC severity and was more abundant than gp41 or iNOS staining, particularly in the white matter. Logistic regression analysis revealed that staining for iNOS and gp41 increased linearly with ADC severity and was significantly more abundant in the basal ganglia compared with the white matter. Double-immunolabeling studies colocalized iNOS predominantly to macrophage/microglia and to gp41-positive cells. The expression of iNOS and gp41 in the basal ganglia combined with immune activation contributes to the development and progression of the clinical syndrome.

AB - The regional expression of immune-mediated and neurotoxic events in the human immunodeficiency virus (HIV)infected brain in relationship to the acquired immunodeficiency syndrome (AIDS) dementia complex (ADC) and brain pathology remains uncertain. The extent of gp41, inducible nitric oxide synthase (iNOS), and HLA-DR expression was examined in the frontal lobe and basal ganglia of 25 patients at varying stages of ADC. The expression of gp41 and iNOS was present predominantly in perivascular cells and most often in the basal ganglia. Staining for gp41 correlated significantly with iNOS in the basal ganglia, whereas the severity of staining for gp41 and iNOS in the basal ganglia and white matter was significantly greater in subjects with moderate to severe dementia compared with those with milder impairment. The degree of macrophage staining in the white matter and basal ganglia also correlated significantly with ADC severity and was more abundant than gp41 or iNOS staining, particularly in the white matter. Logistic regression analysis revealed that staining for iNOS and gp41 increased linearly with ADC severity and was significantly more abundant in the basal ganglia compared with the white matter. Double-immunolabeling studies colocalized iNOS predominantly to macrophage/microglia and to gp41-positive cells. The expression of iNOS and gp41 in the basal ganglia combined with immune activation contributes to the development and progression of the clinical syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0032839688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032839688&partnerID=8YFLogxK

U2 - 10.1002/1531-8249(199908)46:2<207::AID-ANA10>3.0.CO;2-4

DO - 10.1002/1531-8249(199908)46:2<207::AID-ANA10>3.0.CO;2-4

M3 - Article

VL - 46

SP - 207

EP - 216

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 2

ER -